This site is intended for healthcare professionals
News

Johnson & Johnson initiates pivotal global phase III clinical trial of JNJ 78436735, Janssen’s COVID-19 vaccine candidate.

Read time: 2 mins
Last updated:24th Sep 2020
Published:24th Sep 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com